Lifecore Biomedical, Inc.LFCRNASDAQ

|||

Overview News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts lean bullish — 57% recommend buying.

Consensus Rating

Buy

7 analysts·Limited coverage

57%

Rating Distribution

Strong Buy

00%

Buy

457%

Hold

343%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Current price is 14% above analyst consensus — modest downside expected.

Bear Case

$5.00

-34%

Consensus

$6.50

-14%

Bull Case

$8.00

+6%

Price Range7 analysts

Low

Consensus

High

$5.00

$8.00

Current Target

Current Price

$7.56

Above Target

$1.06

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$-0.47(2 analysts)

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+74.34%

EPS—

FY2028

Rev+11.44%

EPS—

FY2029

Rev+13.35%

EPS—

Earnings Surprises

Beat rate:33%(4/12 quarters)

Avg surprise:-129.8%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Oct 4, 2024Stephens

Stephens Reiterates Equal Weight Rating on Lifecore Biomedical (LFCR)

Target:$5.00

-7.1%from $5.38

Sep 5, 2024Craig-Hallum

Craig-Hallum bullish on Lifecore, initiates with a Buy

Target:$8.00

+89.6%from $4.22

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance